These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21354550)

  • 61. Transgender hormone therapy: understanding international variation in practice.
    Mamoojee Y; Seal LJ; Quinton R
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):243-246. PubMed ID: 28340645
    [No Abstract]   [Full Text] [Related]  

  • 62. Beyond Fairness: The Biology of Inclusion for Transgender and Intersex Athletes.
    Pitsiladis Y; Harper J; Betancurt JO; Martinez-Patino MJ; Parisi A; Wang G; Pigozzi F
    Curr Sports Med Rep; 2016; 15(6):386-388. PubMed ID: 27841808
    [No Abstract]   [Full Text] [Related]  

  • 63. Gender transitioning before puberty?
    Steensma TD; Cohen-Kettenis PT
    Arch Sex Behav; 2011 Aug; 40(4):649-50. PubMed ID: 21373942
    [No Abstract]   [Full Text] [Related]  

  • 64. What are the Possibilities of Uterine Transplantation in Transgender Patients?
    Lerner T; Ejzenberg D; Pereyra EAG; Soares Júnior JM; Baracat EC
    Rev Bras Ginecol Obstet; 2017 Oct; 39(10):521-522. PubMed ID: 28847025
    [No Abstract]   [Full Text] [Related]  

  • 65. Estrogens, the be-all and end-all of male hypogonadal bone loss?
    Laurent MR; Gielen E; Vanderschueren D
    Osteoporos Int; 2015 Jan; 26(1):29-33. PubMed ID: 25377497
    [No Abstract]   [Full Text] [Related]  

  • 66. Kidney Disease Prevalence in Transgender Individuals.
    Eckenrode HE; Gutierrez OM; Osis G; Agarwal A; Curtis LM
    Clin J Am Soc Nephrol; 2022 Feb; 17(2):280-282. PubMed ID: 34872973
    [No Abstract]   [Full Text] [Related]  

  • 67. Pap test use is lower among female-to-male patients than non-transgender women.
    Peitzmeier SM; Khullar K; Reisner SL; Potter J
    Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Care of the transgender patient: a survey of gynecologists' current knowledge and practice.
    Unger CA
    J Womens Health (Larchmt); 2015 Feb; 24(2):114-8. PubMed ID: 25525682
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
    Peitzmeier SM; Reisner SL; Harigopal P; Potter J
    J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transgender men who experienced pregnancy after female-to-male gender transitioning.
    Light AD; Obedin-Maliver J; Sevelius JM; Kerns JL
    Obstet Gynecol; 2014 Dec; 124(6):1120-1127. PubMed ID: 25415163
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Qualitative Study of Cervical Cancer Screening Among Lesbian and Bisexual Women and Transgender Men.
    Johnson MJ; Nemeth LS; Mueller M; Eliason MJ; Stuart GW
    Cancer Nurs; 2016; 39(6):455-463. PubMed ID: 26859282
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sex reassignment of transsexual people from a gynecologist's and urologist's perspective.
    Trum HW; Hoebeke P; Gooren LJ
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):563-7. PubMed ID: 25721104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Care of the transgender patient: the role of the gynecologist.
    Unger CA
    Am J Obstet Gynecol; 2014 Jan; 210(1):16-26. PubMed ID: 23707806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uterine and Ovarian Histopathology After Testosterone for Gender Affirmation: A Systematic Review.
    Toland MK; Bonasia K; Bentz J; DelBaugh RM; Vitale EJ; Scudder PN; Damiano EA
    Transgend Health; 2024 Aug; 9(4):288-297. PubMed ID: 39385954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Breast and cervical cancer in transgender men: literature review and a case report.
    Di Lisa FS; Villa A; Filomeno L; Arcuri T; Chiofalo B; Sanguineti G; Pizzuti L; Krasniqi E; Barba M; Sergi D; Lombardo F; Romanelli F; Botti C; Zoccali G; Ciliberto G; Vici P
    Ther Adv Med Oncol; 2024; 16():17588359241259466. PubMed ID: 39131728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Varying Phenotypes of Leydig Cell Hyperplasia of the Ovary: Two Case Reports.
    Caulkins M; Ricciuti J; Desouki M; Mager KL
    Case Rep Obstet Gynecol; 2023; 2023():7178201. PubMed ID: 37588946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery.
    Panichella JC; Araya S; Nannapaneni S; Robinson SG; You S; Gubara SM; Gebreyesus MT; Webster T; Patel SA; Hamidian Jahromi A
    World J Clin Oncol; 2023 Jul; 14(7):265-284. PubMed ID: 37583948
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sexual and Gender Minority Communication Skills (SGM Comskil) Training for Oncology Clinicians: Development, Implementation, and Preliminary Efficacy.
    Banerjee SC; Staley JM; Alexander K; Parker PA; Haviland KS; Moreno A; Walters CB
    Ann LGBTQ Public Popul Health; 2021 Mar; 2(1):35-52. PubMed ID: 37475763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endometrial cancer in a transgender male: A rare case and review of the literature.
    Seay K; Shih K; Kredentser A; Wu D; Schmidt E
    Gynecol Oncol Rep; 2023 Jun; 47():101199. PubMed ID: 37251786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.
    Iwamoto SJ; Defreyne J; Kaoutzanis C; Davies RD; Moreau KL; Rothman MS
    Ther Adv Endocrinol Metab; 2023; 14():20420188231166494. PubMed ID: 37113210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.